Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.78M Sell
657,300
-167,500
-20% -$1.8M ﹤0.01% 3447
2026
Q1
$6.98M Sell
824,800
-339,900
-29% -$3.72M ﹤0.01% 3671
2025
Q4
$13.1M Buy
1,164,700
+22,500
+2% +$279K ﹤0.01% 2703
2025
Q3
$17.1M Buy
1,142,200
+556,000
+95% +$8.09M ﹤0.01% 2367
2025
Q2
$8.27M Buy
586,200
+338,100
+136% +$6.03M ﹤0.01% 3130
2025
Q1
$5.96M Sell
248,100
-34,200
-12% -$1.21M ﹤0.01% 3321
2024
Q4
$10.5M Buy
282,300
+6,500
+2% +$303K ﹤0.01% 2591
2024
Q3
$13.8M Buy
275,800
+168,200
+156% +$6.54M ﹤0.01% 2214
2024
Q2
$3.73M Sell
107,600
-77,500
-42% -$3.06M ﹤0.01% 3920
2024
Q1
$10.1M Sell
185,100
-104,400
-36% -$5.17M ﹤0.01% 2587
2023
Q4
$12.4M Buy
289,500
+89,400
+45% +$2.78M ﹤0.01% 2360
2023
Q3
$5.2M Sell
200,100
-11,300
-5% -$235K ﹤0.01% 3447
2023
Q2
$5.06M Sell
211,400
-2,100
-1% -$36.1K ﹤0.01% 3518
2023
Q1
$2.92M Buy
213,500
+56,800
+36% +$904K ﹤0.01% 4386
2022
Q4
$2.17M Buy
+156,700
New +$2.21M ﹤0.01% 4543

Other funds holding BHVN

Jeff Yass's BHVN Position: Q2 2026 in Review

Jeff Yass reduced its Biohaven (BHVN) stake by 41% in Q2 2026, selling an estimated $1.34M and leaving 181,182 shares worth $2.7M. The position accounts for ﹤0.01% of the portfolio, ranked #5849.

Jeff Yass first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $11M in Q1 2024. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Jeff Yass held 181,182 shares of Biohaven worth $2.7M as of Q2 2026.
  • Jeff Yass sold 124,385 Biohaven shares in Q2 2026, an estimated $1.34M.
  • Biohaven made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5849 holding.
  • Jeff Yass first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • Jeff Yass's Biohaven position peaked at $11M in Q1 2024.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.